(Q35058061)

6 August 2017

0 references

Critical points in the management of pseudohypoaldosteronism type 1. (English)

1 reference

6 August 2017

Tülay Güran

1

1 reference

6 August 2017

Serpil Değirmenci

2

1 reference

6 August 2017

İpek K Bulut

3

1 reference

6 August 2017

Aysun Say

4

1 reference

6 August 2017

Felix G Riepe

5

1 reference

6 August 2017

Ömer Güran

6

1 reference

6 August 2017

8 June 2011

1 reference

Journal of clinical research in pediatric endocrinology

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

2

1 reference

6 August 2017

98-100

1 reference

Clinical and molecular features of type 1 pseudohypoaldosteronism

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119449

PubMed Central

reference URL

Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119449

PubMed Central

reference URL

Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy

25 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21750640

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4274/JCRPE.V3I2.20

1 reference

6 August 2017

1 reference

6 August 2017

1 reference